« Back to Record
Citation APA

Metzger-Filho, O., de Azambuja, E., Bradbury, I., Saini, K., Bines, J., Simon, S., van Dooren, V., Aktan, G., Pritchard, K., Wolff, A. C., Smith, I., Jackisch, C., Lang, I., Untch, M., Boyle, F., Xu, B., Baselga, J., Perez, E. A., & Piccart-Gebhart, M. (2013). Analysis of regional timelines to set up a global phase III clinical trial in breast cancer: The adjuvant lapatinib and/or trastuzumab treatment optimization experience. The oncologist, 18(2), 134-140. doi:10.1634/theoncologist.2012-0342


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/168065

Metzger-Filho, O., de Azambuja, E., Bradbury, I., Saini, K., Bines, J., Simon, S., van Dooren, V., Aktan, G., Pritchard, K., Wolff, A. C., Smith, I., Jackisch, C., Lang, I., Untch, M., Boyle, F., Xu, B., Baselga, J., Perez, E. A., & Piccart-Gebhart, M. (2013). Analysis of regional timelines to set up a global phase III clinical trial in breast cancer: The adjuvant lapatinib and/or trastuzumab treatment optimization experience. The oncologist, 18(2), 134-140. doi:10.1634/theoncologist.2012-0342